Novartis Institutes for BioMedical Research, Inc.'s Net Worth
$92.9 Million
Who is Novartis Institutes for BioMedical Research, Inc.?
Novartis Institutes for BioMedical Research, Inc. has an estimated net worth of $92.9 Million. This is based on reported shares across multiple companies, which include Surface Oncology, Inc., Homology Medicines, Inc., and Intellia Therapeutics, Inc..
SEC CIK
Novartis Institutes for BioMedical Research, Inc.'s CIK is 0001673852
Past Insider Trading and Trends
2016 was Novartis Institutes for BioMedical Research, Inc.'s most active year for acquiring shares with 4 total transactions. Novartis Institutes for BioMedical Research, Inc.'s most active month to acquire stocks was the month of March. 2016 was Novartis Institutes for BioMedical Research, Inc.'s most active year for disposing of shares, totalling 3 transactions. Novartis Institutes for BioMedical Research, Inc.'s most active month to dispose stocks was the month of March. 2018 saw Novartis Institutes for BioMedical Research, Inc. paying a total of $11,499,990.00 for 5,927,708 shares, this is the most they've acquired in one year. In 2017 Novartis Institutes for BioMedical Research, Inc. cashed out on 1,523,000 shares for a total of $27,870,900.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Surface Oncology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.95M |
$15.00 |
—
| 3.95M |
Apr 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Homology Medicines, Inc. (FIXX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.98M |
—
|
—
| 1.98M |
Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Intellia Therapeutics, Inc. (NTLA) Snapshot price: $19.75
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -26.94% | -1.52M |
$18.30 | -$27,870,900.00 | 4.13M |
Dec 12
| |||
Form 4
| +1.42% | 79.25K |
—
|
—
| 5.65M |
Mar 3
| |||
Form 4
|
∞
| 5.57M |
$18.00 |
—
| 5.57M |
May 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |